U.S. Markets open in 2 hrs 13 mins

Cempra, Inc. (CEMP)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
3.150.00 (0.00%)
At close: 4:00PM EDT
People also watch
TTPHESPRFOLDPTCTCLVS
Full screen
Previous Close3.15
Open3.15
Bid3.05 x 2300
Ask3.20 x 500
Day's Range3.10 - 3.20
52 Week Range2.55 - 26.95
Volume269,358
Avg. Volume732,104
Market Cap165.4M
Beta0.67
PE Ratio (TTM)-1.67
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube21 days ago

    ETFs with exposure to Cempra, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cempra, Inc. :CEMP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube27 days ago

    Cempra, Inc. :CEMP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Cempra, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson, Innoviva, Inc., NovaBay Pharmaceuticals, Inc., Emergent BioSolutions Inc. and Altimmune, Inc. (JNJ-US, INVA-US, NBY-US, EBS-US and ALT-US) that have also reported for this ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of CEMP earnings conference call or presentation 9-Aug-17 12:45pm GMT

    Q2 2017 Cempra Inc Earnings and Update on the Merger with Melinta Therapeutics Inc Call